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く〉研究目的 Aims of the research projects 
天然、薬物の臨床利用を目指して，以下のテーマについて研究している。
1) 天然薬物（特に魚油中のDHA ·EPA）の作用機序の解明とその臨床的有効性
2 ）中枢神経系における自然免疫応答に及ぼす和漢薬および食餌性 n-3 系脂肪酸の影響
3 ）遺伝的および環境的要因による脂質代謝異常に対する和漢薬の改善効果
く〉研究概要 Research projects 
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1. 注意欠陥／多動性障害児における二重盲検試験により DHA が集中力をむしろ低下させる可能
性があり（対照群では慣れにより検査値が向上したが， DHA 群では変化がなしウ， DHA は中
枢性ノルアドレナリンを抑制している可能性が考えられる。また，二次的症状である攻撃性は，
DHA で有意に低下した。これもノルアドレナリンの低下と関連すると思われる。














く〉原著 Original papers 
1) Nakamura N., Hamazaki T., Johkaji H~， Minami S., Yamazaki K., Satoh A., Sawazaki S., 
Urakaze M., Kobayashi M.,_ Osawa H., Yamabe H., Okumura K. : Effect of cilostazol on 
serum lipid concentrations and plasma fatty .acid composition in type 2 diab_etic patients wi!h 
peripheral vascular disease. Clin Exp Med., 2: 180~184, 2003~ 
Abstract: Cilostazol is an anti-thrombotic and vasodilating agent, reported to have both anti-thrombotic and cereｭ
bral vasodilating effects. We investigated the effects of cilostazol on serum lipid concentrations and plasma fatty 
acid composition in type 2 diabetic patients with peripheral vascular disease. The serum concentrations of total choｭ
lesterol, triglycerides, high-density lipoprotein-cholesterol, lipoprotein (a), remnant-like particles-cholesterol, 
apolipoproteins,. and plasma fa仕y acid composition were measured in 1 7 diabetic patients with peripheral vascular 
disease before and 1, 3, and 6 months after administration of cilostazol (200 mg/day). Serum triglyceride concen~ra­
tions were significantly decreased after cilostazol （仕om 1.31 ｱ0.17 mmol/l to 0.86 土 0.07 mmol/l at 6 months, 
P<0.01). Plasma cfocosahexaenoic acid levels were significantly _increased after cilostazol (4.11 ｱ0.26% to 4.94ｱ 
0.26% at 6 months, P<0.01). Our findings show that cilostazol can induce some beneficial changes in serum lipid 
profile and plasina fatty acid composition. 
2) Hamazaki K., Itomura M., Mingming Huan, Nishizawa H., .Watanabe S., Hamazaki T., 
Sawazaki S., Terasawa K., Nakajima S., Terano T., Hata Y., Fujishiro S. : n-3 Long-Chain 
FA Decrease Serum Levels of TG and Remnant-Like Particle~Cholesterol in Humans. Lipids., 
38:353・358, 2003. 
Abstract: A large number of papers have reported that administration of n-3 FA reduced serum TG concentrations 
in hypertriglyceridemic patients. However, few studies have examined the effect of n・3 FA on serum concentrations 
of remnant-like particle (RLP) cholesterol. Volunteers (n =41) whose serum TG concentrations were l00.:.300 mg/dL 
were recruited and randomly assigned to either an n・3 FA group or a control group with stratification by sex, age, 
and serum TG level in a double-blind manner. The subjects in the n・3 FA group were administered 125 mL of ferｭ
mented soybean milk with fish oil containing 600 mg of EPA and 260 mg of DHA/d for 12 wk. The controls conｭ
sumed control soybean milk with olive oil. Fasting blood samples were obtained before the start of administration 
and at 4, 8, and 12 wk: EPA concentrations in red blood cels increased significantly in al but one subject in the n-3 
FA group, with no significant changes in the control group. TC levels decreased more in the n-3 FA group than in 
the control group at weeks 4 (P< 0.05), 8 (P< 0.01), and 12 (P< 0.05) with their baseline as covariate. RLP cholesｭ
terol levels decreased more in the n-3 FA group than in the control at weeks 8 (P< 0.01) and 12 (P< 0.05) with their 
baseline as covariate. The 、groupsdid not differ in the other lipid levels. It is likely that n-3 long-chain FA may exert 
anti-atherosclerotic effects by lowering serum TG and RLP-cholesterol levels even at the dose of 860 mg/d. 
3) Harada S., Sugiyama E., Takebe S., Taki H., Shinoda K., S.G.K. Mohamed., Maruyama M., 
Hamazaki T .,and Kobayashi M. : Cooperative induction of 15・lipoxygenase in rheumatoid 
synovial cellsby IL・4 and proinflammatoηr cytokines. Clin. Exp. Rheumatol., 21:753~758, 
2003. 
Abstr~ct Objective: To clari今 the role of interleukin-4 (IL・4) in the expression of 15・lipoxygenase (15-LOX), 
whose metabolites are known to suppress the inflammatory reaction, in freshly prepared rheumatoid synovial cels. 
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Methods: Adherent synovial cells were prepared by enzymatic digestion of synovia obtained from patients with 
rheumatoid arthritis (RA). Protein expression of 15-LOX was determined by Western blot analysis. The messenger 
RNAs of 15・LOXwere determined by 'reverse transcription and the polymerase chain reaction (RT-PCR). 
Results: Freshly prepared rheumatoid synoviaf cells did not express 15,.LOX at either the mRNA or protein levels. 
IL・4 induced the protein expression of 15・LOXafter 24 hours of culture. Although interleukin-1α(IL・1α）and tumor 
necrosis factor α（TNFα）， m勾orinflammatory cytokines in rheumatoid s戸iovia, did not induce the expression of 15・
LOX, IL-4 and these inflammatory cytokines synergistically enhanced the protein expression of 15・LOX. The S戸1・
ergistic effect was also observed at the level of mRNA. 
Conclusions: We demonstrate that IL-4 cooperated with the inflammatory cytokines IL・1αand TNFαto e凶ance
the expression of 15.,LOX in rheumatoid synovial cels. Since 15-ｷLoX metabolites have potent anti-inflammatory 
actions, our data suggest that IL-4 might downregulate rheumatoid inflammation via the induction of 15-LOX and 
its metabolites. 
4) Watanabe S., Doshi M., and Hamazaki T.: n-3 Polyunsaturated h向r add (PUF A) deficiency 
el , evates and n・3 PUFA enrichment reduces brain 2-arachidonoylgllycerol level .in mice. 
Prostaglandins, Leukotrienes and'Essential .Fa的YAcids, 69: 51-59, 2003。
Abstract: 2・Arachidonoylglycerol (2-AG) is a putative endogenous ligand for cannabinoid receptors and was sugｭ
gested to play an important role in both physiological and pathological events in the central nervous system (CNS) 
as well as in peripheral organs. The sequential hydrolysis of arachidonic acid (20:4n-6, AA)-containing phospholipids 
has been proposed as a m勾orbiosynthetic route of 2-AG. On the other hand, the manipulation of the dietary n・3
polyunsaturated fatty acid (PUF A) status changes the AA level in tissue phospholipids. We, therefore, conducted two 
separate experiments to confirm whether the dietary n・3 PUF A status influences the 2-AG level in the mouse brain. 
In the first exp.eriment, we fed mice with n-3 i>UF A・deficient diet, which resulted in a marked decrease in the 
docosahexaenoic acid (22:6n-3, DHA) levels without a change in the AA level in brain phospholipids as compared 
with the mice_ fed with an n-3 PUF A-sufficient diet. The brain 2・AG level in the n-3 PUF A-deficient group was sigｭ
nificantly higher than in the n・3 PUF A sufficient group. In the second experiment, we found that short-term suppleｭ
mentation of DHA・richfish oil reduced brain 2・AGlevel as compared with the supplementation with low n-3 PUF A. 
The decrease in the AA level and the increase in the DHA level in the major phospholipids occurred in the brains 
of the mice fed the fish oil diet compared with those fed the low n-3 PUF A diet. Our results indicate that the n-3 
PUFA deficiency elevates and n-3 PUFA enrichment reduces the brain 2・AG level in mice, suggesting that physioｭ
logical and pathological events mediated by 2-AG through cannabinoid receptor in the CNS could be modified by 
the manipulation of the dietary n・3 PUF A status. 
5) Chiang N., Takano T., Arita M.，明＇atanabe S., and Serban, C.N.: A novel rat lipoxin A4 re-
ceptor that is conserved in structure and function Br. J. Pharmacol., B9: 89-98, 2003. 
Abstract: 1 Lipoxin (LX) A4 and aspirin-triggered-LX (ATL) are endogenous lipid-derived mediators that regulate 
leukocyte trafficking via specific LXA4. receptors (ALX), and are involved in endogenous anti-inflammation and 
resolution. Both LXA4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA4 and ATL exｭ
hibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in 
rat tissues and its potential role in modulating leukocyte trafficking with LXA4 and ATL. 
2 In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 ｵg 
kg-1 each injection, significantly inhibited heutrophil infiltration (-43%) and protein extravasation （・42%)in a caseinｭ
induced peritonitis. 
3 The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein-coupled 
receptor (GPCR). It gave ・ 74and -84% homology, respectively to the deduced amino,.acid sequences of the human 
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and mouse ALX. 
4 Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where 
LXA4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. 
5 The rat orthologue of ALX gave specific radioligand binding with [3H]LXA4 and [1251・Tyr]-annexin I-derived pepｭ
tide with apparent Kd values of 5 and 820 nM, respectively, that are at levels comparable to those of the human 
ALX. 
6 Activation of rat ALX inhibited tumor necrosis factor alpha-mediated nuclear factor kappaB activity in a ligandｭ
dependent manner utilizing a luciferase reporter gene system. 
7 Together, these results are the first demonstration of a rat ALX that is conserved in both s仕uctureand function -sugｭ
gesting that ALX plays key roles in regulating effector immune responses from murine to human species. 
6 ) Du, C., Sato A., Watanabe S, Wu, C圃Z, Ikemoto A., Ando K, Kikugawa K., F吋ii Y:, and 
Okuyama H.: Cholesterol synthesis in mice is suppressed but lipofuscin formation is not afｭ
fected by long-term feeding of n-3 fatty acid-enriched oils compared with lard and n・6 fatty 
acid-enriched oils. Biol. Pharm. Bull., 26: 766-770, 2003. 
Abstract: Hypocholesterolemic activity of dietary po伽msa旬ratedfatty acids is observed、 afterrelatively short-term 
but not long-term feeding and their long-term feedings are suspected to accelerate aging through tissue accumulation 
of lipid peroxides and age pigments (lipofuscin). To define the long-term effects of fats and oils in mote detail; feｭ
male mice were fd a conventional basal diet supplemented with lard (Lar); high-linoleic (n・6) safflower oil (Sat), 
rapeseed oil (Rap), high－ αlinolenic (n-3) perilla oil (Per), or a mixture ofethylｷdocosahexaenoate and Soybean oil 
(DHA/Soy) from 17 weeks to 71 weeks of age. The DHA/Soy and Per groups had decreased serum cholesterol levels 
compared ~ith the Lar and Saf groups, but the difference between the Lar and-Saf groups was ｷnot significant. The 
3-hydroxy-3-methylglutary-CoA (HMG-CoA) reductase activity in the liver was also significantly lower in the Per 
and DHA/Soy_groups. However, no significant difference in lipofuscin contents in the brain and liver was observed 
among the 5 dietary groups, despite significant differences in peroxidizability indices of the dietary and/or tissue lipｭ
ids. These results indicate that n・3 fatty acid-rich oils are hypocholesterolemic by suppressing hepatic HMG-CoA 
reductase activity compared with animal .fats and high-linoleic (n・6) oil, but tissue lipofuscin contents are not afｭ
fected by a long-term feeding of fats and oils with different degree of unsaturation in mice. 
く〉総説 Review papersｷ 
1) Hamazaki T., Okuyama H.: The Japan Society for Lipid Nutrition Recommends to Reduce the Intake of 
Linoleic Acid. A Review and Critique of the Scientific Evidence. Simopoulos AP., Clt'.land LG (eds): 
Omega-6/0mega-3 Essential Fa抗yAcid Ratio: The Scientifo~ Evidence. World Rev Nutr Diet. 92: 109・ 132,
Basel, Karger, 2003. 
2 ）浜崎智仁， j畢崎茂樹，糸村美保，浜崎景，渡辺志朗，平山諭： n-3 系多価不飽和脂肪酸と行動，特集
「機能性食品のトップバッター－ n-3 系多価不飽和脂肪酸－ J，機能性食品と薬理栄養， 1: 153-
158, 2003. 
3 ）渡辺志朗： n-3 多価不飽和脂肪酸の化学・代謝・生理，特集「機能性食品のトッフ。バッター－ n-3 
系多価不飽和脂肪酸－」，機能性食品と薬理栄養， 1 : 129-134, 2003. 
4) 渡辺志朗，浜崎智仁： n-3 系不飽和脂肪酸によるエイコサノイド産生制御，特集「プライマリケア
医のための最新栄養学」，治療， 85 : 107-111, 2003. 
く〉学会報告 Scientific presentation 
1 ）平山論，浜崎智仁，寺津捷年： DHA 含有食品が注意欠陥／多動性障害児に及ぼす影響，日本脂質栄
養学会 2003, 9，東京．
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2 ）仁井本剛，道志勝浜崎智仁渡辺志朗： In vivo での脂質ケミカルメディエーター産生に及ぼすオ
ウゴンの効果，日本薬学会123年会 2003, 3，長崎．
3 ｝道志勝，渡辺志朗，仁井本剛，秋元健吾，木曽良信，浜崎智仁：食餌 DHA および n-9 エイコサトリ
エシ酸がマウスにおける脂質性ケミカルメディエーター産生と急性及び慢性炎症に及ぼす影響，日
本薬学会123年会 2003, 3，長崎．
4) 竹中瑞貴，直井一久，金田智子，浜崎智仁，渡辺志朗： n-3 系脂肪酸給餌が LPS 投与によるマウス
の強制水泳における行動変化に及ぼす影響，日本薬学会123年会 2003, 3，長崎．
5 ）渡辺志朗，金田智子，竹中瑞貴，浜崎智仁： n-3 系脂肪酸給餌による LPS 誘発 sickness behavior 
の抑制，日本薬学会123年会 2003, 3~ 長崎．
6 ）渡辺志朗，金田智子，竹中瑞貴，浜崎智仁： n-3 系脂肪酸給餌によるリポポリサッカライド誘発
sickness behavior の抑制，日本脂質生化学会 2003, 6，仙台
7) 渡辺志朗，金田智子，竹中瑞貴，浜崎智仁： n-3 系脂肪酸給餌による LPS 誘発 sickness behavior 
の抑制，日本脂質栄養学会 2003, 9，東京．
く〉その他 Others 
1 ）浜崎智仁：スタヂン治療に偏っていないか？，リノール酸摂取制限の提言，循環 Plus, 3: 6~ 8, 
2003. 
2 ）浜崎智仁：連載「魚油と人の健康J，アクネット， Vol.6, 8-12号， 2003.
3 ）浜崎智仁：招待講演「脂肪酸と行動」学術フロンティア推進研究組織第三回ワークショップ」杏
林大学， 2003, 2. 3，東京．
4) 浜崎智仁：コレステロールは悪者か？，産経新聞， 2003, 2. 16 
5 ）浜崎智仁：講演「ドコサヘキサエン酸が精神面に与える影響」， JOCS-ILSI Japan Joint Symposium 
2003, 2003, 6~1，東京．
6 ）浜崎智仁：魚油でマラリア予防，北日本新聞， 2003, 7, 28 
7) 浜崎智仁：講演「脂肪酸と精神疾患」．国立がんセンター研究所支部， 20031 10. 17，千葉．
8 ）浜崎智仁：講演「最近の油事情と健康J. 富山県厚生部， 2003, 10. 25，富山．
9 ）浜崎智仁：講演「脂肪酸：医学の新しい切り口」東京農業大学， 2003, 1. 7，東京．
10）浜崎智仁：講演「魚油の薬効に関する基礎から臨床まで」第2 回とやま産学官交流会， 2003. 1. 
11，富山．
く〉共同研究、Co-operative researchs 
1 ）孫 月吉：中国・大連医科大学神経精神医学教授「自殺未遂患者の血中脂肪酸構成」 2000.11～
2 ）平山 論：倉敷市立短期大学「ADHA の治療研究」 2001.6～~2003.
3 ）東原英二：杏林大学医学部泌尿器科学教授「前立腺癌の再発予防研究」 2001.9～
4 ) Insan Tunru, Syafruddin ：インドネシア・ハサヌディン大学，アイクマン研究所「魚油によるマ
ラリア予防のd大規模介入試験J 2002.6~ 












外国人客員研究員： Dr. .Syafruddin （アイクマン研究所研究員，ハサヌディン大学医学部講師
2003,11/27-12/26) 









糸村美保「The Effect of Docosahexaenoic Acid on Phys~cal Aggression . inSchoolchildren-a randomized, 
double-blind, placebo-controlled trial」医学博士（富山医科薬科大学）
